Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant hCG (Ovitrelle) Vesrus Urinary hCG (Pregnyl) for Triggering Final Oocyte Maturation in High Responders

NCT00415766 is registered in ClinicalTrials.gov with Eugonia as lead sponsor.

NCT NCT00415766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00415766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant hCG (Ovitrelle) Vesrus Urinary hCG (Pregnyl) for Triggering Final Oocyte Maturation in High Responders
Lead sponsor
Eugonia
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2013
Completion date
July 31, 2016
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility